Work

Additional file 5: of Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer

Year: 2017
Type: article
Abstract: Tolerance of selinexor in vivo. Body weight–time curve is shown. Data are presented as mean ± SEM. (DOCX 126 kb)
Source: Figshare
Language: English
Open Access status: green
OpenAlex ID: W7135376631
FWCI:
Cites:
Cited by:
Related to: 10